1 / 30
2 / 30
3 / 30
4 / 30
5 / 30
6 / 30
7 / 30
8 / 30
9 / 30
10 / 30
11 / 30
12 / 30
13 / 30
14 / 30
15 / 30
16 / 30
17 / 30
18 / 30
19 / 30
20 / 30
21 / 30
22 / 30
23 / 30
24 / 30
25 / 30
26 / 30
27 / 30
28 / 30
29 / 30
30 / 30
Webfeb 6, 2024 · biktarvy® (bictegravir 50mg/emtricitabine (“ftc”) 200mg/tenofovir alafenamide (“taf”) 25mg) sales increased 7% to $3. 1 billion in the fourth quarter 2023.